Results 111 to 120 of about 459,313 (206)
To stop or not to stop? International physician survey on HER2 targeted therapy for metastatic breast cancer patients in remission. [PDF]
BreastLee HY, Ong WS, Tjan-Heijnen V, Lambertini M, Lu YS, Park KH, Sagara Y, Vidal M, Urruticoechea A, Oliveira M, Ciruelos E, Zdenkowski N, Bedard PL, Ignatiadis M, Lee SC, Sohn J, Zaman K, Werutsky G, Curigliano G, O'Reilly S, Tsang J, Kim SB, Saji S, Ohno S, Adam V, Arahmani A, Caballero C, Yap YS. +27 moreeuropepmc +1 more sourceArtificial Intelligence-Derived Computed Tomography Phenotyping for Cardiovascular Risk Stratification in Transcatheter Mitral Valve Replacement. [PDF]
J Clin MedZillner L, Kerbel T, Sautner P, Wild MG, Hell MM, Kuhn EW, Rudolph TK, Walther T, Conradi L, Zierer A, Maisano F, Russo M, Rosati F, Colli A, Piñón M, Reineke D, Aphram G, Dubois C, Hausleiter J, von Bardeleben RS, Coti I, Loewe C, Zimpfer D, Heinze G, Andreas M. +24 moreeuropepmc +1 more sourceShort-Course Subcutaneous Immunotherapy With Mannan-Conjugated Birch Pollen Allergoids: Consistent Clinical and Immunological Improvements. [PDF]
Clin Transl AllergyRaskopf E, Passamera S, Klimek L, Pfaar O, Neuhof C, Rybachuk A, Katzke N, Sahin H, Allekotte S, Mösges R, Day L, Subiza JL, Casanovas M, Cuevas M, Del Pozo S. +14 moreeuropepmc +1 more sourceEffectiveness of oral anticoagulants in precapillary pulmonary hypertension associated with systemic sclerosis: a EUSTAR cohort study. [PDF]
Rheumatology (Oxford)Farina N, Bellando Randone S, Jenssen-Bjørkekjær H, Sanges S, Carreira P, Airò P, Guiducci S, Giuggioli D, Riemekasten G, Simeón Aznar CP, Bergmann C, Siegert E, Castellví I, Saketkoo LA, de Vries-Bouwstra J, Klemm P, Müller-Ladner U, Balbir-Gurman A, Smith V, Iannone F, Idolazzi L, Denton C, Rosato E, Maurer B, Allanore Y, Tanaka Y, Zanatta E, Truchetet ME, Kuwana M, Martin M, Cauli A, Solanki K, Del Galdo F, Gheorghiu AM, Anic B, Boleto G, Kumánovics G, Andréasson K, Rednic S, Chung LS, Oliveira S, Cadar M, Corrado A, de Souza Müller C, Hsu VM, Levy Y, Moroncini G, Henes J, Balanescu A, De Langhe E, Montecucco C, Sfikakis PP, Iudici M, Heitmann S, Vonk MC, Hoffmann-Vold AM, Distler O, Matucci Cerinic M, Bruni C. +58 moreeuropepmc +1 more sourceClinical characteristics and severity classification in mixed connective tissue disease: a nationwide retrospective study. [PDF]
Rheumatology (Oxford)Kubo S, Kanda Y, Kameda H, Kuwana M, Narazaki H, Fujii T, Fujio K, Muro Y, Akamatsu K, Ohmura K, Ogura T, Shirai Y, Tanabe Y, Nakashima R, Tsuchida Y, Nakayamada S, Hasegawa H, Hirata S, Fukaya S, Kato T, Yasuoka H, Yamashita Y, Kono M, Atsumi T, Tanaka Y. +24 moreeuropepmc +1 more sourceSkin toxicity and effectiveness of first-line enfortumab vedotin plus pembrolizumab for urothelial carcinoma: a prospective multicenter real-world study in Japan. [PDF]
ESMO Real World Data Digit OncolTamura K, Tsujino T, Taoka R, Kobayashi K, Miyake M, Ogawa K, Sasaki Y, Tatarano S, Katayama S, Kato M, Fukuhara H, Abe Y, Oda Y, Minato R, Shigehisa R, Maenosono R, Sugimoto M, Shiraishi K, Fujimoto K, Wada K, Furukawa J, Enokida H, Araki M, Uchida J, Inoue K, Inamoto T, West Japan Uro-oncology Collaboration Group. +26 moreeuropepmc +1 more sourceClinical phenotypes of ANCA-associated vasculitis using ensemble clustering: prognostic and therapeutic insights from two Japanese cohorts. [PDF]
Rheumatology (Oxford)Inoue H, Kida T, Fujioka K, Omura S, Yanagida T, Shimada Y, Kitai J, Seno T, Kohno M, Nakagomi D, Abe Y, Wada M, Takizawa N, Nomura A, Kukida Y, Kondo N, Takagi H, Endo K, Hirata S, Azuma N, Takeuchi T, Fukui S, Kamada K, Yanai R, Matsuo Y, Shimojima Y, Nishioka R, Okazaki R, Takata T, Moriyama M, Takatani A, Miyawaki Y, Shirai T, Dobashi H, Ito T, Matsumoto I, Takada T, Ito-Ihara T, Yajima N, Kawaguchi T, Ikeuchi H, Nakaya I, Shimoyama K, Amano K, Endo T, Ushio Y, Komagata Y, Naniwa T, Kawakami A, Higuchi T, Nagasaka K, Uchida HA, Tamura N, Kawahito Y, J-CANVAS Study and JPVAS Cohort Study Collaborative Group Investigators. +54 moreeuropepmc +1 more source
